How many injections are you willing to endure to preserve the structural integrity of your face and derrière? For a certain segment of the 1 percent, there’s no such thing as too many pricks.
After giving birth to her first child at 41, Jennifer Berger struggled to lose the last 20 pounds of the 50 she gained during her high-risk pregnancy. “I was doing a mix of cardio and weights three to five times a week, tracking everything I ate, and I still couldn’t lose that last bit of baby weight,” said Ms. Berger, a fashion merchandiser in New York.
At her wits’ end, Ms. Berger visited a doctor who suggested she try tirzepatide, marketed under the brand name Mounjaro, a buzzy new diabetes drug approved by the Food and Drug Administration in May 2022. Mounjaro regulates blood sugar, suppresses appetite and, if one is to believe the hushed accounts recently exchanged at an Upper East Side hair salon, makes excess pounds disappear into thin air.
“Everybody is either on it or asking how to get on it,” said Dr. Paul Jarrod Frank, a dermatologist in New York. “We haven’t seen a prescription drug with this much cocktail and dinner chatter since Viagra came to the market.”